Exhaled nitric oxide is reduced in infants with cystic fibrosis
Authors:
- E A G DemoncheauxEDE A G Demoncheaux
- T W HigenbottamTHT W Higenbottam
Open Access
Abstract
BACKGROUND Exhaled nitric oxide levels are low in patients with cystic fibrosis (CF), despite the chronic inflammation present in the airways. This study aimed to determine whether levels of exhaled nitric oxide were reduced prior to the onset of respiratory symptoms in infants with CF. METHODS The levels of exhaled nitric oxide were measured using a chemiluminescence analyser in five infants with CF and 11 healthy control subjects, both groups having a mean age of 48.6 days. RESULTS Mean levels of exhaled nitric oxide were significantly lower in infants with CF than in the control group (4.9 ppb v 12.1 ppb; p=0.01). CONCLUSIONS This finding may be the key to understanding the inflammatory processes in early cystic fibrosis and may lead to novel treatment approaches.Keywords
This publication has 4 references indexed in Scilit:
- Cystic Fibrosis Transmembrane Conductance Regulator–Dependent Regulation of Epithelial Inducible Nitric Oxide Synthase ExpressionAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxideThorax, 1998
- Exhaled nitric oxide in paediatric asthma and cystic fibrosis.Archives of Disease in Childhood, 1996
- Early Pulmonary Inflammation in Infants with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1995